<DOC>
	<DOCNO>NCT00639249</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability SA4503 patient recover recent stroke . Secondary , evaluate efficacy SA4503 compare placebo .</brief_summary>
	<brief_title>Safety Preliminary Efficacy Study SA4503 Subjects Recovering From Ischemic Stroke</brief_title>
	<detailed_description>Further study detail provide M 's Science Corporation :</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>SA 4503</mesh_term>
	<criteria>Key Males females 18 year age old Experienced stroke 48 72 hour randomization A total score &gt; /=4 NIHSS , &gt; /=2 upper low extremity motor score NIHSS Medically neurologically stable within 24 hour prior randomization Key Patients transient ischemic attack Patients stroke progression Unstable cardiac , hepatic , renal disease , major medical disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>